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Abstract: The purpose of this comparative cross-sectional study was
to investigate the use of standardized clinical tests for dry eye in
pediatric patients with active and quiet vernal keratoconjunctivitis
(VKC) and to compare them with healthy children.
We recruited 35 active VKC, 35 inactive VKC, and 70 age-matched
control healthy subjects. Each child underwent a complete eye exam-
ination, including visual analog scale symptoms assessment, biomicro-
scopy, fluorescein break-up time (BUT), corneal fluorescein and
conjunctival lissamine green staining, corneal esthesiometry, Schirmer
test with anesthetic, and meibomian glands inspection and expression.
Active VKC patients showed significantly increased symptoms and
signs of ocular surface disease, compared with the other 2 groups.
Inactive VKC patients, compared with control subjects, showed
increased photophobia (P<0.05; Mann-Whitney U test), conjunctival
lissamine green staining and Schirmer test values, and reduced BUT and
corneal sensitivity [P<0.05 by analysis of variance (ANOVA) least
significant difference posthoc test for BUT and Schirmer; P<0.001 by
Mann-Whitney U test for lissamine green staining and corneal sensi-
tivity].
Our results confirm the association between VKC and short-BUT
dry eye. This syndrome seems to affect the ocular surface in quiescent
phases too, determining abnormalities in tear film stability, epithelial
cells integrity, and corneal nerves function. The very long-term con-
sequences of this perennial mechanism of ocular surface damage have
not been fully understood yet.
(Medicine 94(42):e1648)
Abbreviations: BUT = break-up time, C = healthy control
subjects, IRB = Institutional Review Board, LSD = Leastrancesco Pichi, Sa relli,
Serafino, and Paolo Nucci
INTRODUCTION
P ediatric dry eye may be associated with several congenital,autoimmune, and inflammatory disorders, but it has not
been investigated as well as in adults and its diagnosis is often
overlooked.1 Twenty years ago, researchers from the Keio
University of Tokyo hypothesized an overlap between dry
eye and allergic conjunctivitis,2,3 and more recently, some
reports have shown the synergic effect of these 2 conditions
in affecting tear film dynamics and stability and ocular surface
homeostasis.4–7 This topic is of exceptional clinical relevance
in children, who are more susceptible to the epithelial damage
related to prolonged ocular surface inflammation.8
Vernal keratoconjunctivitis (VKC) is a severe pediatric,
sight-threatening allergic eye disease, which impairs the child’s
quality of life and can lead to severe ocular complications.9
Children with VKC present with severe ocular symptoms,
frequently with giant papillae on the upper tarsal conjunctiva
(cobblestoning appearance), and/or with gelatinous infiltrations
around the limbus surrounding the cornea (Horner–Trantas
dot). If untreated, ocular surface remodeling leads to corneal
ulcers and scars.9
Both epidemiological10 and experimental4,5 studies have
reported the association between severe ocular allergy and dry
eye, but clinical management of VKC is usually focused just on
classical symptoms and signs of active disease and on the risk of
severe corneal involvement.
The purpose of this comparative cross-sectional study waseye in pediatric patients with active and quiet VKC and to
compare them with healthy children.
METHODS
Design and Participants
This comparative cross-sectional study was performed at a
tertiary referral center for pediatric ophthalmology (University
Eye Clinic of San Giuseppe Hospital, Milan, Italy). The pro-
tocol was approved by the local IRB, and the study was
conducted according to the tenets of the Declaration of Helsinki.
Written informed consent was obtained by the parents of
each child.
From December 2014 to February 2015, we consecutively
recruited 35 patients with quiet VKC (defined as no symptoms
or mild discomfort, and absence of corneal abnormalities at the
time of the examination) and 35 age-matched control subjects
(winter C). From April 2015 to May 2015, we consecutively
recruited 35 patients with active VKC (defined as moderate to
severe ocular discomfort including photophobia, papillae on thea, or limbal Horner–Trantas dots clearly
me of the examination) and 35 age-
cts (spring C).
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No patient enrolled as quiet VKC was included in the
subsequently recruited active VKC group. Inclusion criteria
for each enrolled patient were age less than 16 years; history
and previous diagnosis of VKC; and the willingness and
capability of the child to be compliant with tests execution
and informed consent given by parents. Exclusion criteria
were systemic diseases (other than atopy) or therapies with
known effect on the ocular surface; history of Stevens–
Johnson syndrome; chemical, thermal, or radiation injury
to the eye; previous ophthalmic surgery; active VKC with
corneal shield ulcer, and use of topical drugs (other than mast-
cells stabilizers or dual-acting eyedrops) in the 4weeks before
examination.
Healthy control subjects were recruited among children
attending our outpatient clinic for refraction test.
PROCEDURES
Each recruited child underwent a complete eye examin-
ation, including symptoms assessment, biomicroscopy, fluor-
escein break-up time (BUT), corneal fluorescein staining and
conjunctival lissamine green staining, corneal esthesiometry,
Schirmer test with anesthetic, meibomian glands (MGs) inspec-
tion, and expression.
Quantification of dry eye symptoms was performed using
the visual analog scale (VAS). The VAS questionnaire in this
study consisted of 5 questions, each of which had an answer
scale from 0 (no symptom) to 10 (the worst symptom they could
imagine), respectively, for itching, photofobia, dryness,
foreign-body sensation, and burning/pain. The first 2 items
were grouped in a VKC symptoms score (0–20) and the last
3 items were grouped in a dry eye score (0–30).
Corneal and conjunctival staining were evaluated using the
Oxford grading schema11 and corneal apex sensitivity was
assessed by Cochet–Bonnet nylon thread aesthesiomether.
Meiboscopy of the lower eyelid allowed to assess the
degree of MG dropout (score: grade 0, no gland dropout; grade
1, gland dropout in less than half of the inferior tarsus; and grade
2, gland dropout in more than half of the inferior tarsus)12 and
the presence of MG distortion.13 Assessment of obstruction in
MG orifices was conducted by applying digital pressure on the
upper tarsus, after which the degree of ease in expressing MG
secretion (meibum) was evaluated semiquantitatively: grade 0,
clear meibum easily expressed; grade 1, cloudy meibum
expressed with mild pressure; grade 2, cloudy meibum
expressed with more than moderate pressure; and grade 3,
meibum not expressed even with firm pressure.12
Ocular surface tests were performed in the order suggested
by the Diagnostic Methodology Subcommittee of the Inter-
national Dry Eye WorkShop (2007).14
Statistical Analysis
We determined the sample size in order to assess the
average BUT in each VKC group at 5% of type of 1 error
and precision of 1 second in either side. On the basis of
previously published reports,8,15 the standard deviation of
BUT in children was hypothesized to be equal to 3. Because
of the correlation of measures performed on both eyes and to
ensure statistical independence between observations, only 1
randomly chosen eye for each subject was included in
this analysis.
Villani et alAfter verifying the absence of demographical and clinical
differences between winter C and spring C, we considered them
as a single control group of healthy 70 eyes.
2 | www.md-journal.comQuantitative data are expressed as mean standard devi-
ation. Differences among groups were assessed by analysis of
variance (ANOVA) with least significant difference (LSD)
posthoc test for parametric variables and Kruskal–Wallis
one-way analysis of variance for non-parametric variables.
Mann–Whitney U test was used to compare single pairs of
groups for nonparametric variables. Percentages were com-
pared by Chi-square test. Correlations were explored by Spear-
man correlation index.
The minimum criterion for tests of significance was
P value less than 0.05. Missing data were excluded pair-
wise. The statistical analysis was conducted with commer-
cial software (SPSS for Windows, ver. 12.0; SPSS Sciences,
Chicago, IL).
RESULTS
Quiet VKC, active VKC, and control groups showed no
significant differences in age (9.89 3.12, 8.68 3.67,
9.12 5.21, respectively; P¼ n.s., ANOVA), while the percen-
tage of males was higher in the control group (29%, 31%, 47%,
respectively; P<0.001, Chi-square test).
All symptoms assessed by VAS, except dryness, showed
significant differences between active VKC and the other 2
groups (P<0.001; Kruskal–Wallis one-way analysis of var-
iance). Photophobia score was significantly higher in quiet
VKC than in controls (P<0.05; Mann–Whitney U test)
(Table 1). All clinical tests, except MG assessment, showed
significant differences between active VKC and the 2 other
groups (P<0.001; ANOVA for BUT and Schirmer, Kruskal–
Wallis for staining and sensitivity). The same clinical tests,
except corneal fluorescein staining, showed significant differ-
ences between quiet VKC patients and controls too (P<0.05 by
LSD posthoc test for BUT and Schirmer; P<0.001 by Mann–
Whitney U test for lissamine green staining and corneal sen-
sitivity). The examination of MG dropout and expressibility
revealed no differences among the groups, while MG distortion
was more frequent in both VKC groups than in controls
(P<0.001; Chi-square test) (Table 2).
No significant correlations were found among the different
symptoms. Exploring correlations between symptoms and
signs, a positive correlation between photophobia and Schirmer
test value emerged (r¼0.46, P<0.001; Spearman). Among
the clinical signs, significant positive correlations were found
between fluorescein and lissamine staining (r¼0.54,
P<0.001) and between BUT and corneal sensitivity
(r¼0.56, P<0.001), while a negative correlations were
detected between BUT and lissamine green staining (r¼
-0.65, P<0.001).
In VKC patients, comparing symptoms and signs in sub-
jects with and without MG distortion, no significant differences
were found.
DISCUSSION
Previous reports showed tear film disfunction and cytolo-
gical signs of dry eye in patients with severe ocular
allergy.5,15,16 In this study, on the basis of the Clinical Grading
of Vernal Keratoconjunctivitis proposed by Sacchetti et al,17 we
defined and compared quiet VKC (grade 0–1) and active VKC
(grade 2–3). We think that taking ocular surface alterations into
consideration when dealing with VKC may provide new and
Medicine  Volume 94, Number 42, October 2015important information on this disease, which shows a great
variability of clinical manifestations with several alternating
episodes of improvement or relapse per year.17,18
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TABLE 1. Symptoms Assessed by VAS
Itching
(0–10)
Photofobia
(0–10)
Dryness
(0–10)
Foreign-Body
Sensation
(0–10)
Burning/pain
(0–10)
VKC Symptoms
Score (0–20)
Dre Eye
Symptoms
Score (0–30)
Total
Symptoms
Score (0–50)
Quiet VKC 0.49 0.82 0.79 1.05 0.17 0.86 0.43 1.10 0.31 0.90 1.29 1.20 0.91 1.85 2.21 2.32
Active VKC 7.23 2.39 8.69 1.41 0.00 4.60 3.30 5.86 2.95 15.92 2.96 10.46 4.88 26.38 7.14
Controls 0.21 0.61 0.10 0.45 0.13 0.63 0.07 0.35 0.06 0.33 0.31 0.84 0.26 0.85 0.58 1.35
P

<0.001

<0.001

Ns <0.001

<0.001

<0.001

<0.001

<0.001

ns¼ not significant, VAS¼ visual analog scale, VKC¼ vernal keratoconjunctivitis.
By Kruskal–Wallis one-way analysis of variance.
Quiet VKC versus active VKC: P<0.001; Active VKC versus controls: P<0.001; Mann–Whitney U test.
Quiet VKC versus active VKC: P<0.001; Active VKC versus controls: P<0.001; Quiet VKC versus controls: P<0.05; Mann–Whitney U
test.
ont
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toms is well known19 and recent evidences suggest that children
may report less severe symptoms than adult patients.20 In our
study, active VKC patients reported a wide range of symptoms,
characteristic of both severe allergy (itch and photophobia) and
dry eye (foreign body sensation and burning/pain). No subjects
complained about dryness, probably because of tearing and high
tear volume and secretion, as suggested by Schirmer test results.
Despite several objective clinical differences between quiet
VKC and controls, photophobia was the unique symptom with
different values between these 2 groups. According to previous
reports,4,5,15,16 our active VKC patients had reduced BUT and
corneal sensitivity and increased corneal and conjunctival
staining and Schirmer values. These findings, together with
normal results of MG dropout and expressibility assessment,
seem to suggest the presence of a short-BUT dry eye, mainly
due to inflammation and mucin changes. As previously
reported,4,5 inflammation, even in absence of evident aqueous
or lipid deficiency, may affect goblet cells, MUC5AC mRNA
expression, and corneal nerves, leading to tear function altera-
Quiet VKC versus Active VKC: P<0.001; Active VKC versus c
U test.tions. MGs distortion, significantly more frequent in VKC than
in controls, has been previously reported in association with
other types of ocular allergy,13,21 but its clinical role still needs
TABLE 2. Signs of Dry Eye
BUT
(seconds)
Fluorescein
Staining
(0–5)
Lissamine
Green Staining
(0–10)
Cornea
Sensitiv
(millimet
Quiet VKC 7.71 2.64 0.14 0.35 1.37 1.09 5.37 0.
Active VKC 6.31 2.60 1.03 1.07 4.57 2.03 4.49 0.
Controls 13.37 2.93 0.03 0.17 0.19 0.46 5.96 0.
P <0.001

<0.001

<0.001

<0.001

BUT¼ break-up time, LSD¼ least significant difference, MG¼meibom
P by ANOVA. Quiet VKC versus active VKC: P<0.05; Quiet VKC ve
posthoc test.
P by Kruskal–Wallis one-way analysis of variance. Quiet VKC versus a
Whitney U test.
P by Kruskal–Wallis one-way analysis of variance. Quiet VKC versus
VKC versus controls: P<0.001; Mann–Whitney U test.
P by Chi-square test. Quiet VKC versus controls: P<0.001; Activ
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.to be clarified. Our quiet VKC patients, compared with controls,
showed reduced BUT and corneal sensitivity and increased
conjunctival lissamine green staining. To the best of our knowl-
edge, this is the first study reporting standardized assessment of
subclinical tear film dysfunction in quiet VKC. Similar infor-
mation have been indirectly reported in an in vivo confocal
study by Leonardi et al,22 who described nerves and epithelial
changes in patients with different grades of VKC severity,
including mild and paucisymptomatic cases. Our findings of
ocular surface alterations in quiet VKC need to be considered in
the daily management of these pediatric patients and imply that
treating VKC patients to reach a reduction of symptoms and to
avoid severe corneal complications may not be enough. Further
investigations will be important to understand the very long-
term effects of this chronic ocular surface disease.
Although trying to assess ocular surface symptoms in a
research on pediatric patients, the absence of standardized and
dedicated methods may represent a limitation. Furthermore,
children may experience difficulties of comprehension of stan-
dardized questionnaires; in order to try to minimize this incom-
rols: P<0.001; Quiet VKC versus controls: P<0.001; Mann–Whitneyprehension, we decided to use VAS.20 Another limitation of this
study may be the nonuse of high-tech biomarkes, in addition to
standardized clinical tests. In quiet VKC patients, tear and
l
ity
ers)
Schirmer
Test
(millimeters)
MG Dropout
(0–2)
MG
Distortion
(%)
MG
Expressibility
(0–3)
50 19.88 5.23 0.23 0.04 12/35 (34%) 0.08 0.28
83 22.57 7.16 0.23 0.04 14/35 (40%) 0.17 0.51
18 14.27 2.67 0.24 0.03 8/70 (11%) 0.03 0.17
<0.001

ns <0.001

Ns
ian glands, ns¼ not significant, VKC¼ vernal keratoconjunctivitis.
rsus controls: P<0.001; Active VKC versus controls: P<0.001; LSD
ctive VKC: P<0.001; Active VKC versus controls: P<0.001; Mann–
active VKC: P<0.001; Quiet VKC versus controls: P<0.001; Active
e VKC versus controls: P<0.001.
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conjunctival cytology,9 in vivo confocal microscopy,23,24 and
tear film proteins quantification25 could provide important
information on subclinical abnormalities of the ocular surface.
In summary, VKC is a severe form of ocular allergy, and in
addition to typical inflammatory tarsal and/or limbal manifes-
tations, it is associated with tear film dysfunction, affecting tear
film stability, corneal nerves function, and epithelial cells
integrity. These changes seem to persist even in the quiescent
phases of the disease, determining a perennial, not yet fully
understood, potential mechanism of damage of the ocular sur-
face. A deeper understanding of these mechanismsmight lead to
hypothesize the need to add to current VKC management,
mainly aimed to avoid corneal complications and to control
Villani et alsymptoms, measures to prevent the very long-term con-
sequences of protracted, nearly subclinical at alternate stages,
ocular surface disease.ACKNOWLEDGMENTS
Funding: none.
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